Academic background&position

data loading...

1. [SCIE] Bay 11-7082, an NF-κB Inhibitor, Prevents Post-InflammatoryHyperpigmentation Through Inhibition of Inflammationand Melanogenesis [Pigment Cell & Melanoma Research] - 2025-01-01
2. [SCIE] Risk of incident infammatory heart diseaseand autoimmune neural disease in patients withnewly diagnosed psoriatic disease [INTERNATIONAL JOURNAL OF DERMATOLOGY] - 2024-09-01
3. [SCIE] Semaxanib, a VEGF inhibitor, suppresses melanogenesis by modulating CRTC3 independently of VEGF signaling [JOURNAL OF DERMATOLOGICAL SCIENCE] - 2024-09-01
4. [SCIE] Risk of major adverse cardiovascular events and all-cause mortality among patients with psoriatic disease treated with tumor necrosis factor-α and interleukin-12/23 inhibitors: a nationwide population-based cohort study in Korea [JOURNAL OF DERMATOLOGICAL TREATMENT] - 2024-03-01
5. [SCIE] A randomized, double-blinded, vehicle-controlled clinical trial of topical cryosim-1, a synthetic TRPM8 agonist, in prurigo [Journal of Cosmetic Dermatology] - 2024-03-01